One such study conducted by Ley et al. found that DNMT3A is mutated in approximately 25% of patients diagnosed with acute myeloid leukemia (AML); those authors also associated the mutations with an impact on the prognosis of such individuals [23]. Here, DNMT3A is linked to acute myeloid leukemia.